- Home
- Chemicals & Materials
- Oncolytic Virus Market
Oncolytic Virus Market Size (USD 42 M) by 2032 By Types (HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses, Newcastle Disease Virus-based Oncolytic Viruses), By Applications Covered (Pharmaceutical, Health Care) and Regional Forecast to 2032
Detailed TOC of Global Oncolytic Virus Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2031
Table of Content
1 Oncolytic Virus Market Overview
1.1 Product Overview and Scope of Oncolytic Virus Market
1.2 Oncolytic Virus Market Segment by Type
1.2.1 Global Oncolytic Virus Market Sales Volume and CAGR (%) Comparison by Type (2017-2031)
1.3 Global Oncolytic Virus Market Segment by Application
1.3.1 Oncolytic Virus Market Consumption (Sales Volume) Comparison by Application (2017-2031)
1.4 Global Oncolytic Virus Market, Region Wise (2017-2031)
1.4.1 Global Oncolytic Virus Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2031)
1.4.2 United States Oncolytic Virus Market Status and Prospect (2017-2031)
1.4.3 Europe Oncolytic Virus Market Status and Prospect (2017-2031)
1.4.4 China Oncolytic Virus Market Status and Prospect (2017-2031)
1.4.5 Japan Oncolytic Virus Market Status and Prospect (2017-2031)
1.4.6 India Oncolytic Virus Market Status and Prospect (2017-2031)
1.4.7 Southeast Asia Oncolytic Virus Market Status and Prospect (2017-2031)
1.4.8 Latin America Oncolytic Virus Market Status and Prospect (2017-2031)
1.4.9 Middle East and Africa Oncolytic Virus Market Status and Prospect (2017-2031)
1.5 Global Market Size of Oncolytic Virus (2017-2031)
1.5.1 Global Oncolytic Virus Market Revenue Status and Outlook (2017-2031)
1.5.2 Global Oncolytic Virus Market Sales Volume Status and Outlook (2017-2031)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Oncolytic Virus Market
2 Industry Outlook
2.1 Oncolytic Virus Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Oncolytic Virus Market Drivers Analysis
2.4 Oncolytic Virus Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Oncolytic Virus Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Oncolytic Virus Industry Development
3 Global Oncolytic Virus Market Landscape by Player
3.1 Global Oncolytic Virus Sales Volume and Share by Player (2017-2022)
3.2 Global Oncolytic Virus Revenue and Market Share by Player (2017-2022)
3.3 Global Oncolytic Virus Average Price by Player (2017-2022)
3.4 Global Oncolytic Virus Gross Margin by Player (2017-2022)
3.5 Oncolytic Virus Market Competitive Situation and Trends
3.5.1 Oncolytic Virus Market Concentration Rate
3.5.2 Oncolytic Virus Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 Global Oncolytic Virus Sales Volume and Revenue Region Wise (2017-2022)
4.1 Global Oncolytic Virus Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Oncolytic Virus Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Oncolytic Virus Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Oncolytic Virus Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Oncolytic Virus Market Under COVID-19
4.5 Europe Oncolytic Virus Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Oncolytic Virus Market Under COVID-19
4.6 China Oncolytic Virus Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Oncolytic Virus Market Under COVID-19
4.7 Japan Oncolytic Virus Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Oncolytic Virus Market Under COVID-19
4.8 India Oncolytic Virus Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Oncolytic Virus Market Under COVID-19
4.9 Southeast Asia Oncolytic Virus Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Oncolytic Virus Market Under COVID-19
4.10 Latin America Oncolytic Virus Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Oncolytic Virus Market Under COVID-19
4.11 Middle East and Africa Oncolytic Virus Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Oncolytic Virus Market Under COVID-19
5 Global Oncolytic Virus Sales Volume, Revenue, Price Trend by Type
5.1 Global Oncolytic Virus Sales Volume and Market Share by Type (2017-2022)
5.2 Global Oncolytic Virus Revenue and Market Share by Type (2017-2022)
5.3 Global Oncolytic Virus Price by Type (2017-2022)
5.4 Global Oncolytic Virus Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Oncolytic Virus Sales Volume, Revenue and Growth Rate of HSV-based Oncolytic Viruses (2017-2022)
5.4.2 Global Oncolytic Virus Sales Volume, Revenue and Growth Rate of Adenoviruses-based Oncolytic Viruses (2017-2022)
5.4.3 Global Oncolytic Virus Sales Volume, Revenue and Growth Rate of Vaccinia Virus-based Oncolytic Viruses (2017-2022)
5.4.4 Global Oncolytic Virus Sales Volume, Revenue and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses (2017-2022)
5.4.5 Global Oncolytic Virus Sales Volume, Revenue and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses (2017-2022)
6 Global Oncolytic Virus Market Analysis by Application
6.1 Global Oncolytic Virus Consumption and Market Share by Application (2017-2022)
6.2 Global Oncolytic Virus Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Oncolytic Virus Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Oncolytic Virus Consumption and Growth Rate of Pharmaceutical (2017-2022)
6.3.2 Global Oncolytic Virus Consumption and Growth Rate of Health Care (2017-2022)
7 Global Oncolytic Virus Market Forecast (2022-2031)
7.1 Global Oncolytic Virus Sales Volume, Revenue Forecast (2022-2031)
7.1.1 Global Oncolytic Virus Sales Volume and Growth Rate Forecast (2022-2031)
7.1.2 Global Oncolytic Virus Revenue and Growth Rate Forecast (2022-2031)
7.1.3 Global Oncolytic Virus Price and Trend Forecast (2022-2031)
7.2 Global Oncolytic Virus Sales Volume and Revenue Forecast, Region Wise (2022-2031)
7.2.1 United States Oncolytic Virus Sales Volume and Revenue Forecast (2022-2031)
7.2.2 Europe Oncolytic Virus Sales Volume and Revenue Forecast (2022-2031)
7.2.3 China Oncolytic Virus Sales Volume and Revenue Forecast (2022-2031)
7.2.4 Japan Oncolytic Virus Sales Volume and Revenue Forecast (2022-2031)
7.2.5 India Oncolytic Virus Sales Volume and Revenue Forecast (2022-2031)
7.2.6 Southeast Asia Oncolytic Virus Sales Volume and Revenue Forecast (2022-2031)
7.2.7 Latin America Oncolytic Virus Sales Volume and Revenue Forecast (2022-2031)
7.2.8 Middle East and Africa Oncolytic Virus Sales Volume and Revenue Forecast (2022-2031)
7.3 Global Oncolytic Virus Sales Volume, Revenue and Price Forecast by Type (2022-2031)
7.3.1 Global Oncolytic Virus Revenue and Growth Rate of HSV-based Oncolytic Viruses (2022-2031)
7.3.2 Global Oncolytic Virus Revenue and Growth Rate of Adenoviruses-based Oncolytic Viruses (2022-2031)
7.3.3 Global Oncolytic Virus Revenue and Growth Rate of Vaccinia Virus-based Oncolytic Viruses (2022-2031)
7.3.4 Global Oncolytic Virus Revenue and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses (2022-2031)
7.3.5 Global Oncolytic Virus Revenue and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses (2022-2031)
7.4 Global Oncolytic Virus Consumption Forecast by Application (2022-2031)
7.4.1 Global Oncolytic Virus Consumption Value and Growth Rate of Pharmaceutical(2022-2031)
7.4.2 Global Oncolytic Virus Consumption Value and Growth Rate of Health Care(2022-2031)
7.5 Oncolytic Virus Market Forecast Under COVID-19
8 Oncolytic Virus Market Upstream and Downstream Analysis
8.1 Oncolytic Virus Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Oncolytic Virus Analysis
8.6 Major Downstream Buyers of Oncolytic Virus Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Oncolytic Virus Industry
9 Players Profiles
9.1 Theravir
9.1.1 Theravir Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Oncolytic Virus Product Profiles, Application and Specification
9.1.3 Theravir Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 SillaJen
9.2.1 SillaJen Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Oncolytic Virus Product Profiles, Application and Specification
9.2.3 SillaJen Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Pfizer
9.3.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Oncolytic Virus Product Profiles, Application and Specification
9.3.3 Pfizer Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Takara Bio
9.4.1 Takara Bio Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Oncolytic Virus Product Profiles, Application and Specification
9.4.3 Takara Bio Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Cold Genesys
9.5.1 Cold Genesys Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Oncolytic Virus Product Profiles, Application and Specification
9.5.3 Cold Genesys Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Roche
9.6.1 Roche Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Oncolytic Virus Product Profiles, Application and Specification
9.6.3 Roche Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Genelux
9.7.1 Genelux Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Oncolytic Virus Product Profiles, Application and Specification
9.7.3 Genelux Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Otsuka Pharmaceutical Co
9.8.1 Otsuka Pharmaceutical Co Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Oncolytic Virus Product Profiles, Application and Specification
9.8.3 Otsuka Pharmaceutical Co Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Merck
9.9.1 Merck Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Oncolytic Virus Product Profiles, Application and Specification
9.9.3 Merck Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Neotropix
9.10.1 Neotropix Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Oncolytic Virus Product Profiles, Application and Specification
9.10.3 Neotropix Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Latima
9.11.1 Latima Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Oncolytic Virus Product Profiles, Application and Specification
9.11.3 Latima Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Shanghai Sunway Biotech
9.12.1 Shanghai Sunway Biotech Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Oncolytic Virus Product Profiles, Application and Specification
9.12.3 Shanghai Sunway Biotech Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
-
Download FREE Sample Report
Features |
Type of License |
|||
Single User |
Multi User |
Enterprise User |
||
Pricing | US$ 3480 | US$ 5220 | US$ 6960 | |
Number of Users Who can Access the Report |
1 user only |
2 to 10 users |
Unlimited
access within the organization |
|
Free Customization |
NA |
10% |
20% |
|
Permission to Print |
|
|
|
|
Complementary Analyst Support |
1 Month |
3 Months |
6 Months |
|
Access to the Analyst Team (through calls/email) |
Only Email |
|
|
|
Deliverable Format |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount on Your Next Purchase (Applicable for only 1 Report on the sale license type) (offer Valid for a Month Only) |
No Discount |
10% |
20% |
|
Dedicated Account Manager |
|
|
|
|